Naming Conventions for 'Packaged Clinical Drugs'

Dear All,

Please see below member query in relation to naming conventions in the national extension model:

Would it be possible to have agreed names for Packaged Clinical Drugs (VMPPs in the UK) that are combinations as we can see you have these for FSNs but not all PTs (for combination drugs)?

Please see the link below to help with/describe the query:

https://confluence.ihtsdotools.org/pages/viewpage.action?pageId=123904520

 
From the above link, for example, there a single active ingredient substance presentation strength packaged clinical drug: stated and inferred view example, but not for a combination product which would be most useful if you could share.